Brief: Bioxcel Therapeutics - As Of Nov 18, 431 Patent Has Been Accepted For Listing In FDA Approved Drug Products With Therapeutic Equivalence Evaluations
21/11/2024 21:58
Nov 21 (Reuters) - BioXcel Therapeutics Inc BTAI.O :
* BIOXCEL THERAPEUTICS- AS OF NOV 18, 431 PATENT HAS BEEN
ACCEPTED
FOR LISTING IN FDA APPROVED DRUG PRODUCTS WITH THERAPEUTIC
EQUIVALENCE EVALUATIONS
Source text: [https://tinyurl.com/mt5xay6a]
Further company coverage: BTAI.O
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty